According to the report analysis, ‘Global qPCR and dPCR Market Forecast up to 2025’ states that the global qPCR and dPCR market will grow at a CAGR of 9.2% during the forecast period. Whereas, the market has perceived sturdy growth in the past few years and enhancement in the technology with the introduction of highly sensitive, strong and consistent systems in the market. The market is propelled by increasing the ultimatum for the qPCR and dPCR in genetic and molecular testing, rising the private investment and funds, and augmenting the requirement for the biomarker-based tests.
Nonetheless, the report also suggests that there are several key players which are functioning in this market more actively for attaining the high of market share and leading the speedy growth across the globe while developing the working strategies and increasing the investment amount in the several research and development programs includes Thermo Fisher Scientific, Bio-Rad Laboratories, Danaher Corp., Agilent Technologies, Inc., Qiagen N.V., Hoffmann-La Roche, Abbott Laboratories, Promega Corp., Eppendorf AG, BioMerieux S.A., Merck KGaA and several others.
Furthermore, the market endures to produce and is one of the most extensively utilized the technology for the quantification of nucleic acid. The advanced technology has created the device simple, fast, and truthful. Vendors are effectively aiming towards the new product launches and directing towards end-user’s perspective.
Based on the region, the North America region dominated for the principal share of the global qPCR and dPCR market in 2018. The augmented utilization of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory enhanced the tests for rare genetic diseases, cancers, and infectious diseases are fueling the market in North America. The Asia Pacific region is predicted to observe the wildest growth rate owing to the large patient pool and increasing the healthcare expenditure.
However, the sector of product type involves the instruments, reagents and consumables and software and services. Whereas, the reagents and consumables segment engaged the largest share in 2018 owing to its unconventional features and specialty-based operations. Many companies are extremely focusing on delivering even software services. In March 2017, ThermoFisher Scientific attained the Core Informatics, a supplier of the cloud-based platform supporting scientific data management.
Not only has this, based on the applications the market of Qpcr and Dpcr is divided into clinical diagnostics, biomedical research and several others. For instance, the biomedical research registered the maximum share in 2018 followed by the clinical diagnostics. The efficacious completion of Human genome project has fueled the growth of qPCR and dPCR market.
Furthermore, Merger and acquisition have been foremost strategy followed by the key players in the market to continue their leadership in the market. The Thermo Fisher Scientific deployed around USD 5.5 billion on acquisitions in 2016. This is anticipated to augment the offerings and strategic positioning of the company. Yet, it is anticipated that the market of QPCR and DPCR will increase across the globe more positively over the recent decades.
For more information on the research report, refer to below link:-
Ankur Gupta, Head Marketing & Communications